Abstract: The present invention relates to the use of ergot derivatives or ergolines, and in particular of lisuride and terguride for the prophylaxis and treatment of constrictive capillary arteriopathy. Constrictive capillary arteriopathy refers to the diseases pulmonary arterial hypertension, endogenously induced or exogenously induced glomeruloscleroses as well as secondary Raynaud's syndrome.
Type:
Application
Filed:
November 23, 2007
Publication date:
December 31, 2009
Applicant:
ERGONEX PHARMA GMBH
Inventors:
Rudolf Reiter, Johannes Tack, Reinhard Horowski
Abstract: The present invention relates to the use of terguride and proterguride for the prophylaxis and/or the treatment of chronic pain conditions as well as to pharmaceutical compositions comprising terguride and/or proterguride optionally together with an opiate analgesic.
Type:
Application
Filed:
March 21, 2007
Publication date:
September 27, 2007
Applicant:
ERGONEX PHARMA GMBH
Inventors:
GEORG LUDWIG, REINHARD HOROWSKI, HARALD BLIESATH, RUDOLF REITER